IP Library Granted Patent US 10,689,695
Granted Patent B2
US 10,689,695 · App. 15/785,693 · Granted Jun 23, 2020

Multiplex amplification of polynucleotides

Inventors: Mark Andersen (Carlsbad, CA); David Ruff (Oxford, GB)
Assignee: Applied Biosystems, LLC
C12Q1/686C12Q1/6806C12Q1/6827C12Q1/6851
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,689,695
App. No.
15/785,693
Granted
Jun 23, 2020
Kind
B2
Abstract

The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.

Claims (22)

1. A kit for carrying out a two-step amplifications reaction comprising:

(a) a first container or reaction vessel comprising a plurality of amplification primer sets suitable for carrying out a multiplex amplification reaction to produce a plurality of different amplicons and one or more single-stranded oligonucleotide probes complementary to all or a part of one or more of the plurality of different amplicons; and

(b) a second container or reaction vessel comprising a single set of amplification primers suitable for carrying out a singleplex amplification reaction to produce a single amplicon, and a single-stranded oligonucleotide probe complementary to all or a part of the single amplicon.

2. The kit of claim 1 , wherein the single set of amplification primers in the second container or reaction vessel is the same as or nested to one of the plurality of amplification primer sets in the first container or reaction vessel.

3. The kit of claim 1 , wherein the plurality of amplification primer sets comprises at least 100 different amplification primer sets.

4. The kit of claim 1 , wherein the kit further comprises a third container or reaction vessel comprising a DNA polymerase.

5. The kit of claim 1 , wherein the kit further comprises a third container or reaction vessel comprising a reverse transcriptase.

6. The kit of claim 1 , wherein at least 60% of the plurality of amplification primer sets in the first container or reaction vessel are at approximately an equimolar concentration relative to one another.

7. The kit of claim 6 , wherein all of the plurality of amplification primer sets in the first container or reaction vessel are at approximately an equimolar concentration relative to one another.

8. The kit of claim 1 , wherein the concentration of each of the plurality of amplification primer sets is at a concentration less than 100 nM for each primer.

9. The kit of claim 1 , wherein the concentration of each of the plurality of amplification primer sets is at a concentration of about 30 to 45 nM for each primer.

10. The kit of claim 1 , wherein the one or more single-stranded oligonucleotide probes in the first container or reaction vessel is a TaqMan probe.

11. The kit of claim 1 , wherein the single-stranded oligonucleotide probe in the second container or reaction vessel is detectably labeled.

12. The kit of claim 1 , wherein the single-stranded oligonucleotide probe in the second container or reaction vessel is a TaqMan probe.

13. The kit of claim 1 , wherein at least one step of the two-step amplification reaction is a reverse transcription polymerase chain reaction (RT-PCR).

14. The kit of claim 1 , wherein the first container or reaction vessel further comprises a DNA polymerase and/or a reverse transcriptase.

15. The kit of claim 1 , wherein the second container or reaction vessel further comprises a DNA polymerase and/or a reverse transcriptase.

16. The kit of claim 4 , wherein the DNA polymerase is at a concentration of about 4-6 U/20 μL reaction volume.

17. The kit of claim 8 , wherein the concentration of the single set of amplification primers in the second container or reaction vessel is at a concentration of about 300-900 nM for each primer.

18. The kit of claim 2 , wherein the single set of amplification primers in the second container or reaction vessel and one of the plurality of amplification primer sets in the first container or reaction vessel are the same.

19. The kit of claim 1 , wherein the plurality of amplification primer sets in the first container or reaction vessel and the single set of amplification primers in the second container or reaction vessel all have a Tm that is within 10 degrees of one another.

20. The kit of claim 1 , wherein the one or more single-stranded oligonucleotide probes in the first container or reaction vessel is as the same as the single-stranded oligonucleotide probe in the second container or reaction vessel.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2018
From: ANDERSEN, MARK R.; RUFF, DAVID W.
To: APPLERA CORPORATION
Reel/Frame 047168/0410 →
CHANGE OF NAME Recorded Oct 15, 2018
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 047168/0807 →
MERGER Recorded Oct 15, 2018
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 047168/0973 →
Continuity (6)
Division 14752396 · Jun 26, 2015
Continuation 13645264 · Oct 4, 2012
Continuation 10723520 · Nov 26, 2003
Provisional Application 60525284 · Nov 25, 2003
Provisional Application 60431156 · Dec 4, 2002
Related Publication 20180135104A1 · May 17, 2018